PSC
INSP icon

Prentiss Smith & Co’s Inspire Medical Systems INSP Stock Holding History

Prentiss Smith & Co’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,521
Closed -$1.99M – 64
2023
Q1 		$1.99M Sell
8,521
-187
-2% -$47.3K 1.48% 25
2022
Q4 		$2.19M Sell
8,708
-11
-0.1% -$2.35K 1.99% 18
2022
Q3 		$1.55M Sell
8,719
-85
-1% -$17.1K 1.37% 26
2022
Q2 		$1.61M Sell
8,804
-25
-0.3% -$4.99K 1.24% 27
2022
Q1 		$2.27M Buy
+8,829
New +$2.02M 1.36% 28

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Prentiss Smith & Co's INSP Position: Q2 2023 in Review

Prentiss Smith & Co sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 8,521 shares — an estimated $1.99M sold.

Prentiss Smith & Co first reported a position in INSP in Q1 2022 and held it in 5 quarters. The position peaked at $2.27M in Q1 2022. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

  • Prentiss Smith & Co reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
  • Prentiss Smith & Co sold 8,521 Inspire Medical Systems shares in Q2 2023, an estimated $1.99M.
  • Prentiss Smith & Co first reported a position in Inspire Medical Systems in Q1 2022 and held it in 5 quarters.
  • Prentiss Smith & Co's Inspire Medical Systems position peaked at $2.27M in Q1 2022.
  • 407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Prentiss Smith & Co's 13F filing for Q2 2023, filed 2 Aug 2023.